未登录Characterization of innate lymphoid cells in infants with human cytomegalovirus infection人巨细胞病毒感染婴儿中固有淋巴细胞的表征
Li, Lubei; Yang, Qinglan; Liu, Xinjia; Li, Sai; Zhao, Sha; Ye, Zhichun; Yi, Sisi; Li, Yana; Peng, Hongyan; Wu, Shuting; Hao, Fei; Deng, Youcai; Deng, Yafei .png)
分享.png)
收藏分享 收藏 分享 收藏 Intracranial Histiocytic Neoplasms: Clinical and Pathological Diagnostic Experience Based on the WHO-HAEM5 Classification of a Single CenterYang, Sizhe; Chen, Zihang; Li, Gandi; Liu, Weiping; Zhao, Sha; Zhang, Zhang; Jiang, Lili; Zhang, Hongying; Deng, Yujiao; Ye, Yunxia; Gao, Li-min; Zhang, Wen 分享 收藏 分享 收藏 Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer (vol 189, 112919, 2023)非小细胞肺癌奥希替尼耐药后的肿瘤微环境变化（vol 189, 112919, 2023）Han, Ruoshuang; Guo, Haoyue; Shi, Jinpeng; Wang, Haowei; Zhao, Sha; Jia, Yijun; Liu, Xiaozhen; Li, Jiayu; Cheng, Lei; Zhao, Chao; Li, Xuefei; Zhou, Caicun 分享 收藏 Interventions to improve illness-related communication between cancer patients and their minor children: A systematic review改善癌症患者与其未成年子女之间疾病相关沟通的干预措施: 系统评价Zhao, Sha; Xiao, Jinnan; Liu, Jiayi; Tao, Hong; Liu, Huan; Chen, Jiarui; Bai, Yang; Ding, Jinfeng; Tang, Siyuan; Huang, Hui 分享 收藏 Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasisZhao, Jia-Li; Lin, Bi-Lin; Luo, Chen; Yi, Yan-ling; Huang, Peng; Chen, Yu; Zhao, Sha; Huang, Zhen-Jie; Ma, Xin-Yi; Huang, Long 分享 收藏 Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer( Vol 22, pg 405, 2024)Han, Ruoshuang; Guo, Haoyue; Shi, Jinpeng; Zhao, Sha; Jia, Yijun; Liu, Xiaozhen; Liu, Yiwei; Cheng, Lei; Zhao, Chao; Li, Xuefei; Zhou, Caicun 分享 收藏 Surufatinib plus toripalimab combined with pemetrexed (A), and platinum (P) in patients (pts) with advanced non-squamous non-small cell lung cancer (nsq-NSCLC): Updated results of a single-center, phase II trial苏鲁法替尼 plus 托瑞帕利姆单抗 combined with 帕emetrexed (A), and platinum (P) in patients (pts) with advanced non-squamous non-small cell lung cancer (nsq-NSCLC): Updated results of a single-center, phase II trialFang, W. F.; Yang, Y.; Huang, Y.; Zhao, Y.; Zhang, Y.; Zhou, T.; Chen, G.; Zhao, S.; Ma, Y.; Hong, S.; Zhao, H.; Zhang, L. 分享 收藏 分享 收藏 Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancerHan, Ruoshuang; Guo, Haoyue; Shi, Jinpeng; Zhao, Sha; Jia, Yijun; Liu, Xiaozhen; Liu, Yiwei; Cheng, Lei; Zhao, Chao; Li, Xuefei; Zhou, Caicun 分享 收藏 Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancerHan, Ruoshuang; Guo, Haoyue; Shi, Jinpeng; Wang, Haowei; Zhao, Sha; Jia, Yijun; Liu, Xiaozhen; Li, Jiayu; Cheng, Lei; Zhao, Chao; Li, Xuefei; Zhou, Caicun 分享 收藏 The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratificationYang, Yefan; Ding, Ying; Gong, Yuxi; Zhao, Sha; Li, Mingna; Li, Xiao; Song, Guoxin; Zhai, Boya; Liu, Jin; Shao, Yang; Zhu, Liuqing; Pang, Jiaohui; Ma, Yutong; Ou, Qiuxiang; Wu, Xue; Zhang, Zhihong 分享 收藏 分享 收藏 Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune MicroenvironmentChen, Peixin; Wang, Hao; Zhao, Lishu; Guo, Haoyue; Zhang, Liping; Zhang, Wei; Sun, Chenglong; Zhao, Sha; Li, Wei; Zhu, Jun; Yu, Jia; Wu, Chunyan; He, Yayi 分享 收藏 Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapyJiang, Minlin; Jia, Keyi; Wang, Lei; Li, Wei; Chen, Bin; Liu, Yu; Wang, Hao; Zhao, Sha; He, Yayi; Zhou, Caicun 分享 收藏 Aberrant methylation modifications reflect specific drug responses in small cell lung cancerChen, Peixin; Guo, Haoyue; Liu, Yu; Chen, Bin; Zhao, Sha; Wu, Shengyu; Li, Wei; Wang, Lei; Jia, Keyi; Wang, Hao; Jiang, Minlin; Tang, Xuzhen; Qi, Hui; Dai, Chunlei; Ye, Junyan; He, Yayi 分享 收藏 分享 收藏 Concurrent use of metformin enhances the efficacy of EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer-an option for overcoming EGFR-TKI resistance同时使用二甲双胍可增强晚期EGFR突变型非小细胞肺癌患者egfr-tki的疗效-克服egfr-tki耐药的一种选择Han, Ruoshuang; Jia, Yijun; Li, Xuefei; Zhao, Chao; Zhao, Sha; Liu, Sangtian; Liu, Yiwei; Chen, Donglai; Zhang, Qian; Liu, Xiaozhen; Shi, Jinpeng; Li, Jiayu; Zhou, Caicun 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
